Corning Incorporated vs Personalis Inc. Common Stock — how do they compare? Corning Incorporated trades at $136.24 (market cap $121.36B), while Personalis Inc. Common Stock trades at $15.97 (market cap $1.70B). The key difference: Corning Incorporated is far larger — about 71.4× Personalis Inc. Common Stock's market cap, and Corning Incorporated pays a 0.79% dividend while Personalis Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Corning Incorporated for 36 Days and Personalis Inc. Common Stock for 0 Days on average.
| GLW | PSNL | |
|---|---|---|
Market Cap | $121.36B | $1.70B |
Volume | 7,874,233 | 3,262,398 |
Sector | Technology | Health |
52-Week High | $255.79 | $18.38 |
52-Week Low | $78.03 | $5.04 |
Typical Hold Time | 36 Days | 0 Days |
Enterprise Value | $128.24B | $1.52B |
Dividend Yield | 0.79% | — |
Signals from Pluang's Aura AI — not financial advice
Corning (GLW) trades at $148.52, up 0.87% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from a $3B AT&T fiber deal and improving fundamentals. Revenue grew to $15.63B in 2025 with net income margin expanding to 11.2%. Analyst consensus remains bullish with a $171.25 price target despite ongoing legal investigations.
GLW presents a mixed outlook with strong business fundamentals offset by technical weakness. The AT&T partnership and AI infrastructure demand provide growth catalysts, but high valuation multiples and legal scrutiny pose risks. Wall Street maintains buy ratings, projecting 15% upside from current levels.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Corning Inc is a leader in materials science, specializing in the production of glass, ceramics and optical fiber. The firm supplies its products for a wide range of applications, from flat-panel displays in televisions to gasoline particulate filters in automobiles to optical fiber for broadband access, with a leading share in many of its end markets.
Read more on GLW →Personalis Inc. is a cancer genomics company that provides tumor- and blood-based DNA and RNA sequencing tests, including its NeXT Personal liquid biopsy test for cancer monitoring.
Read more on PSNL →